PTX Media related, page-1022

Every thing you said above makes sense. However, I don't really agree with your point about publicly pumping our collaboration at risk of Omnicar being a flop. I don't think that is TF's worry. Other big pharma willingly allowed their collaboration to be pumped by small biotech without such fear of failure. And there have been many such failures.

My take is the unwillingness to have their name attached to PTX yet is simply to keep share price down. This way, when successful, they can gobble up PTX in one small mouthful. Or they can let PTX pump it up and then have to take several mouthful to swallow PTX. TF ain't no fool. And it is precisely that I believe there is a plot in allowing PTX to own the IP without fuss. It is just simply too good to be true as far as I am concerned.

Anyway, that is my take. And as I said, you also make very valid points. Only time will tell. Every which way, PTX shareholders will win out in the end. Just a matter of how big.